<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="case-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Cytogenet</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol Cytogenet</journal-id>
<journal-title-group>
<journal-title>Molecular Cytogenetics</journal-title>
</journal-title-group>
<issn pub-type="epub">1755-8166</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27980677</article-id>
<article-id pub-id-type="pmc">5135744</article-id>
<article-id pub-id-type="publisher-id">298</article-id>
<article-id pub-id-type="doi">10.1186/s13039-016-0298-9</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A 18p11.23-p11.31 microduplication in a boy with psychomotor delay, cerebellar vermis hypoplasia, chorioretinal coloboma, deafness and GH deficiency</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Giordano</surname>
<given-names>Mara</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Muratore</surname>
<given-names>Valentina</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Babu</surname>
<given-names>Deepak</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Meazza</surname>
<given-names>Cristina</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4882-3714</contrib-id>
<name>
<surname>Bozzola</surname>
<given-names>Mauro</given-names>
</name>
<address>
<phone>+39 0382 501270</phone>
<email>mauro.bozzola@unipv.it</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<aff id="Aff1"><label>1</label>Laboratory of Genetics, Department of Health Sciences, University of Eastern Piedmont, Novara, Italy </aff>
<aff id="Aff2"><label>2</label>Internal Medicine and Therapeutics Department, Pediatric and Adolescent Unit, University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>3</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>3</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>9</volume>
<elocation-id>89</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>9</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>11</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2016</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p>Rearrangements involving the short arm of chromosome 18 have been extensively described. Here we report a microduplication of 320.5–431.5 Kb at 18p11.31-p11.23 in a 10 year-old boy.</p>
</sec>
<sec>
<title>Case presentation</title>
<p>In a 10 year-old boy with moderate psychomotor delay, hypoplasia of the cerebellar vermis, chorioretinal coloboma, deafness and growth hormone deficiency (GHD), an interstitial microduplication at 18p11.31-p11.23 was identified by array-CGH. This maternally inherited microduplication, encompasses three genes, namely <italic>ARHGAP28</italic>, <italic>LINC00668</italic> and <italic>LAMA1</italic> (a gene involved in cerebellum and retinal development).</p>
</sec>
<sec>
<title>Conclusions</title>
<p>The genotype-phenotype is discussed with particular attention to the <italic>LAMA1</italic> gene, although it is difficult, as in many other similar situations, to assess the causality of the detected duplication in the absence of further studies aiming to explore the presence of co-occurring variants that could explain the incomplete penetrance.</p>
</sec>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (doi:10.1186/s13039-016-0298-9) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>18p11.31-p11.23 microduplication</kwd>
<kwd>Growth hormone deficiency</kwd>
<kwd>Hypoplasia of the cerebellar vermis</kwd>
<kwd>Chorioretinal coloboma</kwd>
<kwd>Deafness</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2016</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p>Rearrangements involving the short arm of chromosome 18 have been extensively described in the literature [<xref ref-type="bibr" rid="CR1">1</xref>]. In most cases, patients carrying deletions of the whole arm (18p-syndrome), with breakpoints close to the centromeric region have been reported. The primary features of this condition include a cognitive impairment of varying severity, speech delay, short stature, holoprosencephaly, ptosis, pectus excavatum and dysmorphic features [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. Pituitary hormone deficiencies have also been reported [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Conversely, 18p duplications are rare events in cytogenetic findings and only few cases are represented by pure duplications [<xref ref-type="bibr" rid="CR1">1</xref>], being associated in most of the patients with 18q s or resulting from the unbalanced segregation of parental reciprocal translocations. For these patients, the phenotypic features could be the result of the excess of chromosome 18p material along with the imbalance of other chromosome regions.</p>
<p>Interestingly, there have been no reports of large interstitial duplication of 18p; nevertheless, with the introduction of microarrays some microduplications, with a likely pathogenic effect, have been identified. An 18p11.31-p11.32 duplication of 429.5 Kb, including four genes, among which the likely causative <italic>EMILIN2</italic>, has been identified in a family with porokeratosis of Mibelli [<xref ref-type="bibr" rid="CR6">6</xref>]. In the same region, other authors [<xref ref-type="bibr" rid="CR7">7</xref>] detected a larger overlapping 2.6 Mb microduplication involving at least nine genes in two siblings with variable levels of intellectual disability/developmental delay and behavioral difficulties. Finally, Kashevarova et. al [<xref ref-type="bibr" rid="CR8">8</xref>] reported a microduplication of 351 kb at 18p11.32 in a boy with autism and dysmorphisms.</p>
<p>Here we report a microduplication of 320.5–431.5 Kb at 18p11.31-p11.23 identified through array comparative genomic hybridization (aCGH), not overlapping with the previously described one, encompassing three genes, namely <italic>ARHGAP28</italic>, <italic>LINC00668</italic> and <italic>LAMA1</italic> in a 10 year-old boy with moderate psychomotor delay, hypoplasia of the cerebellar vermis, chorioretinal coloboma, deafness and growth hormone deficiency (GHD). The functional role of laminin alpha 1 in cerebellum and retinal development suggests that the duplication of <italic>LAMA1</italic> may be responsible for at least some of the patient’s clinical features.</p>
</sec>
<sec id="Sec2">
<title>Case presentation</title>
<p>A 7.5 year-old boy, the second child of non-consanguineous Caucasian healthy parents (father 33 years-old, with a height of 161.5 cm and mother 36 years-old, 166.1 cm) was referred to our Department because of short stature. His height was 110 cm (−2.25 standard deviation score (SDS), weight 17 Kg (body mass index (BMI) −4.78 SDS) and bone age 6.5 years. An intrauterine growth restriction was documented by ultrasound scan between the 20th and 22nd week of gestation. Labor was induced due to interruption of fetal development and fetal distress at 33 weeks. The birth weight was 1,450 g (−1.81 SDS), birth length 41 cm (−1.49 SDS) and head circumference 28 cm (−2.29 SDS). Apgar scores were 6 and 9 at 1 and 5 min. He required intubation and mechanical ventilation because of pneumothorax. He was discharged from the Neonatal Intensive Care Unit after 37 days with the diagnosis of chorioretinal coloboma. The patient’s family history was not significant for chromosome abnormalities, developmental delay or intellectual disability. His 3 year-old sister was healthy.</p>
<p>At 1 year of age, brain magnetic resonance image (MRI) showed lateral and third ventricle enlargement, stenosis of the aqueduct of Silvio and decrease dimensions of cerebellar vermis. These pathologic features were later confirmed by further MRI.</p>
<p>The patient had a history of significant developmental delay and intellectual disability. He sat at 13 months and walked at 2 years. He achieved language acquisition at 4 years and required speech therapist and psychologist care. At the age of 6 year the patient was diagnosed with bilateral mixed hypoacusis. At the age of 9.5 years, his intelligence quotient (IQ) was 49.</p>
<p>He presented dysmorphic features including microcephaly, triangular face, high forehead, protruding low set ears, small teeth, micrognathia, esotropia, epicanthus, right palpebral ptosis and flat feet (Fig. <xref ref-type="fig" rid="Fig1">1a</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>
<bold>a</bold> Dismorphic features of the patient at 7.5 years of age. Microcephaly, triangular face, high forehead, protruding low set ears, micrognathia, esotropia, epicanthus, right palpebral ptosis are shown. <bold>b</bold> Height curve of the subject. The <italic>arrow</italic> indicates the start of GH substitutive therapy</p></caption><graphic id="MO1" xlink:href="13039_2016_298_Fig1_HTML"></graphic></fig>
</p>
<p>At the age of 7.5 years, he was investigated because of short stature. After exclusion of celiac disease, malabsorption, inflammatory bowel disease, hypothyroidism and other chronic diseases, GH response to two pharmacological stimuli (arginine and glucagon) revealed a GHD (GH peaks: 4.8 and 8.1 ng/ml, respectively; normal values &gt;10 ng/ml). No other pituitary hormone deficiencies were found to be associated. MRI of the hypothalamic-pituitary region revealed a flattened pituitary gland (Fig. <xref ref-type="fig" rid="Fig2">2a, b</xref>). Substitutive GH therapy (0.21 mg/Kg subdivided into 6 weekly subcutaneous injections) was started and led to a satisfactory increase in height (Fig. <xref ref-type="fig" rid="Fig1">1b</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><p>Magnetic resonance imaging of the hypothalamic-pituitary region. Flattened pituitary gland. <bold>a</bold> coronal view. <bold>b</bold> sagittal view</p></caption><graphic id="MO2" xlink:href="13039_2016_298_Fig2_HTML"></graphic></fig>
</p>
</sec>
<sec id="Sec3">
<title>Methods</title>
<sec id="Sec4">
<title>Array Comparative Genomic Hybridization (aCGH) analysis</title>
<p>DNA was extracted from whole blood of the patient by salting out method and the Concentration and purity was measured with the NanoDrop spectrophotometer (NanoDrop Technologies, Inc.). Array CGH was performed using the standard Agilent Human Genome G3 SurePrint 4 × 180 K Microarray (Agilent Technologies, California, USA), with median spacing of 13 Kb. Labeling and hybridization were carried out according to the manufacturer’s instruction (Agilent Technologies, California, USA).</p>
<p>The image of the array was acquired using the Agilent laser scanner G2565CA (Agilent Technologies, California, USA) and analyzed with the Agilent Feature Extraction software (v10.10.1.1.). Results were analyzed by Agilent Cytogenomics software (v2.5.8.11).</p>
<p>The presence of the duplication was confirmed in the patient and searched in his relatives through MLPA (Multiplex Ligation Probe Amplification) with a probe specifically designed within <italic>LAMA1</italic> (chr18:7014093–7014542; GRCh37/hg19) using the SALSA MLPA probemix P200-A1 Human DNA Reference-1 (MRC-Holland).</p>
<p>Copy number variations (CNVs) reported in the Database of Genomic Variants [<xref ref-type="bibr" rid="CR9">9</xref>] were excluded from further analysis.</p>
<p>We performed a search in DECIPHER database [<xref ref-type="bibr" rid="CR10">10</xref>] and ClinGen [<xref ref-type="bibr" rid="CR11">11</xref>] to search for patients carrying similar micro-duplications.</p>
</sec>
<sec id="Sec5">
<title>Sequencing</title>
<p>The <italic>CDH7</italic> and <italic>LIG4</italic> genes were screened for the presence of causative mutations by direct sequencing. Briefly, genomic DNA was amplified by polymerase chain reaction (PCR) using primers designed to specifically amplify the coding regions and the intron/exon boundaries of each gene (see Additional file <xref ref-type="media" rid="MOESM1">1</xref>) The PCR products were visualized on a 2% agarose gel and purified using ExoSAP-IT enzymatic PCR clean up system (Affimetrix, Santa Clara, CA). The purified products were, then, sequenced with the Big Dye Terminator kit (Applied Biosystems, Foster City, CA) and the automatic sequencer ABI PRISM 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA).</p>
</sec>
</sec>
<sec id="Sec6">
<title>Results</title>
<p>At the age of 8 years, short stature, reduced head circumference, cognitive delay and facial dysmorphisms led to investigation of the <italic>LIG4</italic> gene involved in Dubowitz syndrome (OMIM #223370): no mutation was identified. Because of clinical features including chorioretinal coloboma, growth failure, developmental retardation and hearing loss, CHARGE syndrome (OMIM#214800) was suggested at the age of 9 years. Sequencing of the <italic>CHD7</italic>, whose mutation explains about 90% of cases of CHARGE syndrome, excluded this gene as the cause of the patient’s phenotype.</p>
<p>The array-CGH performed at the age of 10 years showed the presence of an interstitial microduplication at 18p11.31-p11.23 (6,813,085 × 2, 6,825,044–7,157,962 × 3, 7,193,872 × 2) of 332,9–380,7 Kb (Fig. <xref ref-type="fig" rid="Fig3">3a</xref>). The same duplication, tested through MLPA, was present in the mother of the patient, but not in the father and in the older sister (Fig. <xref ref-type="fig" rid="Fig3">3b</xref>). Actually, the apparently healthy mother upon a closer evaluation revealed some mild clinical features of the son, such as partially hearing loss and mild micrognathia. She had a normal head size and her performance at school was within the normal range.<fig id="Fig3"><label>Fig. 3</label><caption><p>18p11.31-p11.23 duplication. <bold>a</bold> Pedigree of the family. The <italic>arrow</italic> indicates the proband. dup = duplication, wt = absence of the duplication. <bold>b</bold> Graphic representation of part of 18p11.23-p11.31 (corresponding to the region included in <italic>red box</italic> depicted in the chromosome 18 ideogram) with the genes included in this region. The duplication detected in our patient at 18p11.31-p11.23 18p11.23-p11.31 (6,813,085 × 2, 6,825,044–7,157,962 × 3, 7,193,872 × 2) -ranging from 332,9 to 380,7 Kb is represented by a <italic>green rectangle</italic> above the boxed region. Genomic positions refer to the Human Genome February 2009 assembly (GRCh37/hg19). <bold>c</bold> Schematic representation of the microduplications (smaller than 2.7 Mb) in this region reported in the DECIPHER and ISCA database. The ID of each patient is reported. The clinical features of the patients are reported in parentheses below the corresponding duplication as described in Decipher [<xref ref-type="bibr" rid="CR10">10</xref>] and ClinGen [<xref ref-type="bibr" rid="CR11">11</xref>]</p></caption><graphic id="MO3" xlink:href="13039_2016_298_Fig3_HTML"></graphic></fig>
</p>
<p>The duplicated region was examined using the human resource websites at NCBI [<xref ref-type="bibr" rid="CR12">12</xref>] and the archive EnsEMBL [<xref ref-type="bibr" rid="CR13">13</xref>]. This region contains 3 genes, encoding for a member of the Rho guanosine triphosphatases (<italic>ARHGAP28</italic>), the laminin subunit α1 (<italic>LAMA1</italic>) and a long intergenic non-coding RNA (<italic>LINC00668</italic>) of unknown function.</p>
</sec>
<sec id="Sec7">
<title>Conclusions</title>
<p>Most microdeletions and microduplications encompass several genes with various functions, creating a challenge in understanding the role of the genes involved in the phenotype. Occasionally, however, these mutations encompass only few genes. Such cases are of special interest in contributing to the understanding of effects of dosage variations of the included genes.</p>
<p>Here we report a 18p micro-duplication including three genes in a patient with intellectual disability, deafness, GHD and other clinical features. The duplication was inherited from the unaffected mother. In contrast to microdeletions, the interpretation of microduplications often remains unsolved as the functional consequences of these alterations are not well understood. However, analyzing the role of the three genes included in the rearrangement, namely <italic>ARHGAP28</italic>, <italic>LINC00668</italic>, <italic>LAMA1</italic>, might help to elucidate, at least in part, the genotype-phenotype relationship.</p>
<p>The <italic>ARHGAP28</italic> encodes for a Rho GTPase activating protein (RhoGAP) that switches RhoA into its inactive form by stimulating the ability of Rho GTPase to hydrolyze GTP to GDP. The Rho GTPases are important in the regulation of reorganization of the actin during the formation of stress fibers. In particular it has been recently reported that in mice Arhgap28 might act as a negative regulator of RhoA, during the formation of actin stress fibers in cells of mesenchymal origin [<xref ref-type="bibr" rid="CR14">14</xref>]. LINC00668 encodes for a long intergenic non coding RNA whose function has not been reported but similarly to the other non coding RNA it might be involved in the regulation of gene expression.</p>
<p>Among the genes included in the duplication, the best known is <italic>LAMA1</italic> as it has also been found mutated in humans and animal models. Laminins are a large family of heterotrimeric glycoproteins consisting of a α, β and γ chain present in the extracellular matrix, essential for the basement membrane assembly and critical for early embryonic development [<xref ref-type="bibr" rid="CR15">15</xref>]. <italic>LAMA1</italic> encodes for the alpha-1 subunit of the Laminin-111 heterotrimer, formed by α1, β1 and γ1. Hypomorphic and null <italic>LAMA1</italic> mutations in mice and zebrafish cause defects in the retinal inner, limiting membrane development, abnormal retinal blood vessel formation and progressive cell loss from the inner nuclear and ganglion cell layers [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. In humans, <italic>LAMA1</italic> biallelic mutations have been identified in patients affected by cerebellar dysplasia with cysts, presenting defects in the retina development, including retinal dystrophy, absent pigment and atrophy [<xref ref-type="bibr" rid="CR18">18</xref>]. However, both human and mice phenotypes are determined by inactivating mutations with the consequent absence of a functional product during retinal and cerebellum development, whereas here we detected a duplication of the gene containing region.</p>
<p>We can speculate that an excess of <italic>LAMA1</italic> may be involved in the cerebellum and retinal defects observed in our patient by perturbing the interaction with the other subunits in Laminin-111 formation, thus contributing to the cerebellar vermis hypoplasia and retinal coloboma. Alternatively, the long intergenic non-coding RNA (<italic>LINC00668</italic>) located downstream of the gene, might be involved in <italic>LAMA1</italic> transcription regulation and the increased level of this non-coding transcript might alter the local chromatin structure and consequently affect transcription of the nearby genes [<xref ref-type="bibr" rid="CR19">19</xref>].</p>
<p>Regarding the hearing loss, it is intriguing that laminins have been detected at multiple sites in human and rodent inner ears [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. Furthermore, the <italic>dy</italic> mouse, a mutant model for congenital muscular dystrophy defective for laminin-α2, also presents hearing loss [<xref ref-type="bibr" rid="CR22">22</xref>], thus confirming the pleiotropic effect of laminins and reinforcing the evidence of their involvement in deafness.</p>
<p>Although duplications encompassing <italic>LAMA1</italic> are not reported in the literature, seven patients with similar partial or complete overlapping imbalances, including this gene, are present in the DECIPHER [<xref ref-type="bibr" rid="CR10">10</xref>] and ISCA Databases [<xref ref-type="bibr" rid="CR11">11</xref>] (Fig. <xref ref-type="fig" rid="Fig3">3c</xref>). Remarkably, some of these patients present clinical features resembling those observed in our patient, such as hearing impairment in #285404 and #252483 and hearing impairment in association with hypoplasia of the cerebellar vermis in #285404 or Coloboma in nssv584041 and intellectual disability in #252391. In all these patients, the minimal critical region contains <italic>LAMA1</italic> (Fig. <xref ref-type="fig" rid="Fig3">3c</xref>). However, against the involvement of this duplication in the clinical phenotype is the observation that duplications including <italic>LAMA1</italic> also represent rare CNVs as reported in the DGV [<xref ref-type="bibr" rid="CR9">9</xref>].</p>
<p>In any case, the interpretation of the role of this duplication remains challenging, also considering the paucity of similar rearrangements on 18p described in literature. To the best of our knowledge, there are only three interstitial submicroscopic duplications reported involving 18p and none of them overlaps with the one described here [<xref ref-type="bibr" rid="CR6">6</xref>–<xref ref-type="bibr" rid="CR8">8</xref>]. In all of these cases, the microduplication was either inherited from a healthy parent [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>], as in the here presented case, or it was present in unaffected family members [<xref ref-type="bibr" rid="CR6">6</xref>], in accordance with a dominant model of inheritance with incomplete penetrance. The variability in the phenotype of patients carrying the same unbalances, ranging from severe disorders to healthy phenotype, might be explained with the presence of additional anomalies in the affected patients. This additional hit has been demonstrated in cases in which the aCGH revealed the presence of a second rearrangement that might operate through an additive model or by modifying the phenotype [<xref ref-type="bibr" rid="CR23">23</xref>]. Further studies are required to establish the pathogenicity of this variation. Similarly to other imbalances with reduced penetrance and variable expressivity, it can be suspected that there might be other co-occurring variations not detectable with conventional aCGH. The complex phenotype of the here described patient could be the consequence of different and independent genetic defects and for example GHD could be determined by a causative mutation in some other gene.</p>
</sec>
</body>
<back>
<app-group>
<app id="App1">
<sec id="Sec8">
<title>Additional file</title>
<p>
<media id="MOESM1" position="anchor" xlink:href="13039_2016_298_MOESM1_ESM.docx"><label>Additional file 1:</label><caption><p>Supplementary Methods. (DOCX 22 kb)</p></caption></media>
</p>
</sec>
</app>
</app-group>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>aCGH</term>
<def>
<p>Array comparative genomic hybridization</p>
</def>
</def-item>
<def-item>
<term>GHD</term>
<def>
<p>Growth hormone deficiency</p>
</def>
</def-item>
<def-item>
<term>BMI</term>
<def>
<p>Body mass index</p>
</def>
</def-item>
<def-item>
<term>SDS</term>
<def>
<p>Standard deviation score</p>
</def>
</def-item>
<def-item>
<term>MRI</term>
<def>
<p>Magnetic resonance image</p>
</def>
</def-item>
<def-item>
<term>IQ</term>
<def>
<p>Intelligence quotient</p>
</def>
</def-item>
<def-item>
<term>CNVs</term>
<def>
<p>Copy number variations</p>
</def>
</def-item>
</def-list>
</glossary>
<ack>
<title>Acknowledgements</title>
<p>The authors are grateful to Susan West for the English revision of the paper.</p>
<sec id="FPar1">
<title>Funding</title>
<p>Not applicable.</p>
</sec>
<sec id="FPar2">
<title>Availability of data and materials</title>
<p>Data sharing not applicable to this article as no datasets were generated or analysed during the current study.</p>
</sec>
<sec id="FPar3">
<title>Authors’ contributions</title>
<p>MG and DB performed the genetic analysis and drafted the paper, VM collected the data of the patient, CM and MB contributed in writing the manuscript. All authors read and approved the final manuscript.</p>
</sec>
<sec id="FPar4">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<sec id="FPar5">
<title>Consent for publication</title>
<p>Parents’ patient have given their informed written consent for publication of the present case report.</p>
</sec>
<sec id="FPar6">
<title>Ethics approval and consent to participate</title>
<p>Parents’ patient have given their informed written consent for their son’s participation to this study.</p>
</sec>
</ack>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hasi-Zogaj</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sebold</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Heard</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Soileau</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rupert</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Perry</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Atkinson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>O’Donnell</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gelfond</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lancaster</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fox</surname>
<given-names>PT</given-names>
</name>
<name>
<surname>Hale</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Cody</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>A review of 18p deletions</article-title>
<source/>Am J Med Genet C Semin Med Genet
          <year>2015</year>
<volume>169</volume>
<fpage>251</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.c.31445</pub-id>
<pub-id pub-id-type="pmid">26250845</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taine</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Goizet</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>ZQ</given-names>
</name>
<name>
<surname>Chateil</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Battin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Saura</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lacombe</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>18p monosomy with midline defects and a de novo satellite identified by FISH</article-title>
<source/>Ann Genet
          <year>1997</year>
<volume>40</volume>
<fpage>158</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="pmid">9401105</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tonk</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Krishna</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Case report: denovo inherited 18p deletion in a mother-fetus pair with extremely variable expression, confirmed by fluorescence in situ hybridization (FISH) analysis</article-title>
<source/>Eur J Obstet Gynecol Reprod Biol
          <year>1997</year>
<volume>73</volume>
<fpage>193</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1016/S0301-2115(97)02749-8</pub-id>
<pub-id pub-id-type="pmid">9228504</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Artman</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Stock</surname>
<given-names>AD</given-names>
</name>
</person-group>
<article-title>18p- syndrome and hypopituitarism</article-title>
<source/>J Med Genet
          <year>1992</year>
<volume>29</volume>
<fpage>671</fpage>
<lpage>2</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.29.9.671</pub-id>
<pub-id pub-id-type="pmid">1404301</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Portnoï</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Gruchy</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Marlin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Finkel</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Denoyelle</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Dubourg</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Odent</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Siffroi</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Le Bouc</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Houang</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Midline defects in deletion 18p syndrome: clinical and molecular characterization of three patients</article-title>
<source/>Clin Dysmorphol
          <year>2007</year>
<volume>16</volume>
<fpage>247</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="doi">10.1097/MCD.0b013e328235a572</pub-id>
<pub-id pub-id-type="pmid">17786116</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Occella</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bleidl</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Nozza</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mascelli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Raso</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gimelli</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gimelli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tassano</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Identification of an interstitial 18p11.32-p11.31 duplication including the <italic>EMILIN2</italic> gene in a family with porokeratosis of Mibelli</article-title>
<source/>PLoS One
          <year>2013</year>
<volume>8</volume>
<fpage>e61311</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0061311</pub-id>
<pub-id pub-id-type="pmid">23593459</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balasubramanian</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sithambaram</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Inherited duplication of the short arm of chromosome 18p11.32-p11.31 associated with developmental delay/intellectual disability</article-title>
<source/>Clin Dysmorphol
          <year>2016</year>
<volume>25</volume>
<fpage>19</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1097/MCD.0000000000000097</pub-id>
<pub-id pub-id-type="pmid">26287558</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kashevarova</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Nazarenko</surname>
<given-names>LP</given-names>
</name>
<name>
<surname>Skryabin</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Salyukova</surname>
<given-names>OA</given-names>
</name>
<name>
<surname>Chechetkina</surname>
<given-names>NN</given-names>
</name>
<name>
<surname>Tolmacheva</surname>
<given-names>EN</given-names>
</name>
<name>
<surname>Sazhenova</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Magini</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Graziano</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Romeo</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kučinskas</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lebedev</surname>
<given-names>IN</given-names>
</name>
</person-group>
<article-title>Array CGH analysis of a cohort of Russian patients with intellectual disability</article-title>
<source/>Gene
          <year>2014</year>
<volume>536</volume>
<fpage>145</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.1016/j.gene.2013.11.029</pub-id>
<pub-id pub-id-type="pmid">24291026</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<mixed-citation publication-type="other">Database of Genomic Variants: <ext-link ext-link-type="uri" xlink:href="http://dgv.tcag.ca/dgv/app/home">http://dgv.tcag.ca/dgv/app/home</ext-link>. Accessed 1 Sept 2016.</mixed-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<mixed-citation publication-type="other">DECIPHER v9.10: Mapping the clinical genome: <ext-link ext-link-type="uri" xlink:href="https://decipher.sanger.ac.uk/">https://decipher.sanger.ac.uk</ext-link>. Accessed 1 Sept 2016.</mixed-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<mixed-citation publication-type="other">Clin Gen-Clinical Genome Resource: <ext-link ext-link-type="uri" xlink:href="https://www.clinicalgenome.org/">https://www.clinicalgenome.org</ext-link>. Accessed 1 Sept 2016.</mixed-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<mixed-citation publication-type="other">NCBI Human Genome Resources: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/genome/guide/human">http://www.ncbi.nlm.nih.gov/projects/genome/guide/human</ext-link>. Accessed 1 Sept 2016.</mixed-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<mixed-citation publication-type="other">EnsEMBL Ensemble Genome Broser 85: <ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org/index.html">http://www.ensembl.org/index.html</ext-link>. Accessed 1 Sept 2016.</mixed-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yeung</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Garva</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>Zeef</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Soininen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Boot-Handford</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Kadler</surname>
<given-names>KE</given-names>
</name>
</person-group>
<article-title>Arhgap28 is a RhoGAP that inactivates RhoA and downregulates stress fibers</article-title>
<source/>PLoS One
          <year>2014</year>
<volume>9</volume>
<fpage>e107036</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0107036</pub-id>
<pub-id pub-id-type="pmid">25211221</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Domogatskaya</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rodin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tryggvason</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Functional diversity of laminins</article-title>
<source/>Annu Rev Cell Dev Biol
          <year>2012</year>
<volume>28</volume>
<fpage>523</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-cellbio-101011-155750</pub-id>
<pub-id pub-id-type="pmid">23057746</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edwards</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Mammadova-Bach</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Alpy</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hicks</surname>
<given-names>WL</given-names>
</name>
<name>
<surname>Roux</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Simon-Assmann</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Orend</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Peachey</surname>
<given-names>NS</given-names>
</name>
<name>
<surname>Naggert</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Lefebvre</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Nishina</surname>
<given-names>PM</given-names>
</name>
</person-group>
<article-title>Mutations in Lama1 disrupt retinal vascular development and inner limiting membrane formation</article-title>
<source/>J Biol Chem
          <year>2010</year>
<volume>285</volume>
<fpage>7697</fpage>
<lpage>711</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M109.069575</pub-id>
<pub-id pub-id-type="pmid">20048158</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edwards</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>McLeod</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Grebe</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Heng</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lefebvre</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Lutty</surname>
<given-names>GA</given-names>
</name>
</person-group>
<article-title>Lama1 mutations lead to vitreoretinal blood vessel formation, persistence of fetal vasculature, and epiretinal membrane formation in mice</article-title>
<source/>BMC Dev Biol
          <year>2011</year>
<volume>11</volume>
<fpage>60</fpage>
<pub-id pub-id-type="doi">10.1186/1471-213X-11-60</pub-id>
<pub-id pub-id-type="pmid">21999428</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aldinger</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Mosca</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Tétreault</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dempsey</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Ishak</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Hartley</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Phelps</surname>
<given-names>IG</given-names>
</name>
<name>
<surname>Lamont</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>O’Day</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Basel</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gripp</surname>
<given-names>KW</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Stephan</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Bernier</surname>
<given-names>FP</given-names>
</name>
<name>
<surname>Boycott</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Majewski</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Mutations in LAMA1 cause cerebellar dysplasia and cysts with and without retinal dystrophy</article-title>
<source/>Am J Hum Genet
          <year>2014</year>
<volume>95</volume>
<fpage>227</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2014.07.007</pub-id>
<pub-id pub-id-type="pmid">25105227</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>IncRNAs: insights into their function and mechanics in underlying disorders</article-title>
<source/>Mutat Res Rev Mutat Res
          <year>2014</year>
<volume>762</volume>
<fpage>1</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.1016/j.mrrev.2014.04.002</pub-id>
<pub-id pub-id-type="pmid">25485593</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamashita</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bagger-Sjoback</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wersall</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The presence of laminin in the fetal human inner ear</article-title>
<source/>Eur Arch Otorhinolaryngol
          <year>1991</year>
<volume>248</volume>
<fpage>479</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="doi">10.1007/BF00627638</pub-id>
<pub-id pub-id-type="pmid">1768411</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodgers</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Barritt</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Miner</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Cosgrove</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>The laminins in the murine inner ear: developmental transitions and expressions in cochlear basement membranes</article-title>
<source/>Hear Res
          <year>2001</year>
<volume>158</volume>
<fpage>39</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.1016/S0378-5955(01)00283-0</pub-id>
<pub-id pub-id-type="pmid">11506935</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pillers</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Kempton</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Duncan</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dwinnell</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Trune</surname>
<given-names>DR</given-names>
</name>
</person-group>
<article-title>Hearing loss in the laminin-deficient dy mouse model of congenital muscular dystrophy</article-title>
<source/>Mol Genet Metab
          <year>2002</year>
<volume>76</volume>
<fpage>217</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="doi">10.1016/S1096-7192(02)00039-2</pub-id>
<pub-id pub-id-type="pmid">12126936</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Girirajan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Antonacci</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Siswara</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Itsara</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vives</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>T</given-names>
</name>
<name>
<surname>McCarthy</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mefford</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Kidd</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Browning</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Browning</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Dickel</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Ballif</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Platky</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Farber</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Gowans</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Wetherbee</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Asamoah</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Weaver</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Mark</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Dickerson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Garg</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Ellingwood</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Banks</surname>
<given-names>VC</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>W</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Hoo</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>French</surname>
<given-names>BN</given-names>
</name>
<name>
<surname>Hudson</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Ozmore</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Moeschler</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Surti</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Escobar</surname>
<given-names>LF</given-names>
</name>
<name>
<surname>El-Khechen</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gorski</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Kussmann</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Salbert</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lacassie</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Biser</surname>
<given-names>A</given-names>
</name>
<name>
<surname>McDonald-McGinn</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Zackai</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Deardorff</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Shaikh</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Haan</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Friend</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Fichera</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Romano</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gécz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>DeLisi</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Sebat</surname>
<given-names>J</given-names>
</name>
<name>
<surname>King</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Shaffer</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Eichler</surname>
<given-names>EE</given-names>
</name>
</person-group>
<article-title>A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay</article-title>
<source/>Nat Genet
          <year>2010</year>
<volume>42</volume>
<fpage>203</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1038/ng.534</pub-id>
<pub-id pub-id-type="pmid">20154674</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>